Antiangiogenic gene therapy of solid tumor by systemic injection of polyplex micelles loading plasmid DNA encoding soluble flt-1

Makoto Oba, Yelena Vachutinsky, Kanjiro Miyata, Mitsunobu Kano, Sorato Ikeda, Nobuhiro Nishiyama, Keiji Itaka, Kohei Miyazono, Hiroyuki Koyama, Kazunori Kataoka

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

In this study, a polyplex micelle was developed as a potential formulation for antiangiogenic gene therapy of subcutaneous pancreatic tumor model. Poly(ethylene glycol)-poly(l-lysine) block copolymers (PEG-PLys) with thiol groups in the side chain of the PLys segment were synthesized and applied for preparation of disulfide cross-linked polyplex micelles through ion complexation with plasmid DNA (pDNA) encoding the soluble form of vascular endothelial growth factor (VEGF) receptor-1 (sFlt-1), which is a potent antiangiogenic molecule. Antitumor activity and gene expression of polyplex micelles with various cross-linking rates were evaluated in mice bearing subcutaneously xenografted BxPC3 cell line, derived from human pancreatic adenocarcinoma, and polyplex micelles with optimal cross-linking rate achieved effective suppression of tumor growth. Significant gene expression of this micelle was detected selectively in tumor tissue, and its antiangiogenic effect was confirmed by decreased vascular density inside the tumor. Therefore, the disulfide cross-linked polyplex micelle loading sFlt-1 pDNA has a great potential for antiangiogenic therapy against subcutaneous pancreatic tumor model by systemic application.

Original languageEnglish
Pages (from-to)501-509
Number of pages9
JournalMolecular Pharmaceutics
Volume7
Issue number2
DOIs
Publication statusPublished - Apr 5 2010
Externally publishedYes

Fingerprint

Micelles
Genetic Therapy
Plasmids
Injections
DNA
Neoplasms
Disulfides
Vascular Endothelial Growth Factor Receptor-1
Gene Expression
Sulfhydryl Compounds
Blood Vessels
Adenocarcinoma
Ions
Cell Line
Growth

Keywords

  • Antiangiogenic tumor gene therapy
  • Block copolymer
  • Polymeric micelle
  • SFlt-1

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Molecular Medicine
  • Drug Discovery

Cite this

Antiangiogenic gene therapy of solid tumor by systemic injection of polyplex micelles loading plasmid DNA encoding soluble flt-1. / Oba, Makoto; Vachutinsky, Yelena; Miyata, Kanjiro; Kano, Mitsunobu; Ikeda, Sorato; Nishiyama, Nobuhiro; Itaka, Keiji; Miyazono, Kohei; Koyama, Hiroyuki; Kataoka, Kazunori.

In: Molecular Pharmaceutics, Vol. 7, No. 2, 05.04.2010, p. 501-509.

Research output: Contribution to journalArticle

Oba, M, Vachutinsky, Y, Miyata, K, Kano, M, Ikeda, S, Nishiyama, N, Itaka, K, Miyazono, K, Koyama, H & Kataoka, K 2010, 'Antiangiogenic gene therapy of solid tumor by systemic injection of polyplex micelles loading plasmid DNA encoding soluble flt-1', Molecular Pharmaceutics, vol. 7, no. 2, pp. 501-509. https://doi.org/10.1021/mp9002317
Oba, Makoto ; Vachutinsky, Yelena ; Miyata, Kanjiro ; Kano, Mitsunobu ; Ikeda, Sorato ; Nishiyama, Nobuhiro ; Itaka, Keiji ; Miyazono, Kohei ; Koyama, Hiroyuki ; Kataoka, Kazunori. / Antiangiogenic gene therapy of solid tumor by systemic injection of polyplex micelles loading plasmid DNA encoding soluble flt-1. In: Molecular Pharmaceutics. 2010 ; Vol. 7, No. 2. pp. 501-509.
@article{25eb87adf39141e4a81253f9c9a1d9f8,
title = "Antiangiogenic gene therapy of solid tumor by systemic injection of polyplex micelles loading plasmid DNA encoding soluble flt-1",
abstract = "In this study, a polyplex micelle was developed as a potential formulation for antiangiogenic gene therapy of subcutaneous pancreatic tumor model. Poly(ethylene glycol)-poly(l-lysine) block copolymers (PEG-PLys) with thiol groups in the side chain of the PLys segment were synthesized and applied for preparation of disulfide cross-linked polyplex micelles through ion complexation with plasmid DNA (pDNA) encoding the soluble form of vascular endothelial growth factor (VEGF) receptor-1 (sFlt-1), which is a potent antiangiogenic molecule. Antitumor activity and gene expression of polyplex micelles with various cross-linking rates were evaluated in mice bearing subcutaneously xenografted BxPC3 cell line, derived from human pancreatic adenocarcinoma, and polyplex micelles with optimal cross-linking rate achieved effective suppression of tumor growth. Significant gene expression of this micelle was detected selectively in tumor tissue, and its antiangiogenic effect was confirmed by decreased vascular density inside the tumor. Therefore, the disulfide cross-linked polyplex micelle loading sFlt-1 pDNA has a great potential for antiangiogenic therapy against subcutaneous pancreatic tumor model by systemic application.",
keywords = "Antiangiogenic tumor gene therapy, Block copolymer, Polymeric micelle, SFlt-1",
author = "Makoto Oba and Yelena Vachutinsky and Kanjiro Miyata and Mitsunobu Kano and Sorato Ikeda and Nobuhiro Nishiyama and Keiji Itaka and Kohei Miyazono and Hiroyuki Koyama and Kazunori Kataoka",
year = "2010",
month = "4",
day = "5",
doi = "10.1021/mp9002317",
language = "English",
volume = "7",
pages = "501--509",
journal = "Molecular Pharmaceutics",
issn = "1543-8384",
publisher = "American Chemical Society",
number = "2",

}

TY - JOUR

T1 - Antiangiogenic gene therapy of solid tumor by systemic injection of polyplex micelles loading plasmid DNA encoding soluble flt-1

AU - Oba, Makoto

AU - Vachutinsky, Yelena

AU - Miyata, Kanjiro

AU - Kano, Mitsunobu

AU - Ikeda, Sorato

AU - Nishiyama, Nobuhiro

AU - Itaka, Keiji

AU - Miyazono, Kohei

AU - Koyama, Hiroyuki

AU - Kataoka, Kazunori

PY - 2010/4/5

Y1 - 2010/4/5

N2 - In this study, a polyplex micelle was developed as a potential formulation for antiangiogenic gene therapy of subcutaneous pancreatic tumor model. Poly(ethylene glycol)-poly(l-lysine) block copolymers (PEG-PLys) with thiol groups in the side chain of the PLys segment were synthesized and applied for preparation of disulfide cross-linked polyplex micelles through ion complexation with plasmid DNA (pDNA) encoding the soluble form of vascular endothelial growth factor (VEGF) receptor-1 (sFlt-1), which is a potent antiangiogenic molecule. Antitumor activity and gene expression of polyplex micelles with various cross-linking rates were evaluated in mice bearing subcutaneously xenografted BxPC3 cell line, derived from human pancreatic adenocarcinoma, and polyplex micelles with optimal cross-linking rate achieved effective suppression of tumor growth. Significant gene expression of this micelle was detected selectively in tumor tissue, and its antiangiogenic effect was confirmed by decreased vascular density inside the tumor. Therefore, the disulfide cross-linked polyplex micelle loading sFlt-1 pDNA has a great potential for antiangiogenic therapy against subcutaneous pancreatic tumor model by systemic application.

AB - In this study, a polyplex micelle was developed as a potential formulation for antiangiogenic gene therapy of subcutaneous pancreatic tumor model. Poly(ethylene glycol)-poly(l-lysine) block copolymers (PEG-PLys) with thiol groups in the side chain of the PLys segment were synthesized and applied for preparation of disulfide cross-linked polyplex micelles through ion complexation with plasmid DNA (pDNA) encoding the soluble form of vascular endothelial growth factor (VEGF) receptor-1 (sFlt-1), which is a potent antiangiogenic molecule. Antitumor activity and gene expression of polyplex micelles with various cross-linking rates were evaluated in mice bearing subcutaneously xenografted BxPC3 cell line, derived from human pancreatic adenocarcinoma, and polyplex micelles with optimal cross-linking rate achieved effective suppression of tumor growth. Significant gene expression of this micelle was detected selectively in tumor tissue, and its antiangiogenic effect was confirmed by decreased vascular density inside the tumor. Therefore, the disulfide cross-linked polyplex micelle loading sFlt-1 pDNA has a great potential for antiangiogenic therapy against subcutaneous pancreatic tumor model by systemic application.

KW - Antiangiogenic tumor gene therapy

KW - Block copolymer

KW - Polymeric micelle

KW - SFlt-1

UR - http://www.scopus.com/inward/record.url?scp=77950575701&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950575701&partnerID=8YFLogxK

U2 - 10.1021/mp9002317

DO - 10.1021/mp9002317

M3 - Article

VL - 7

SP - 501

EP - 509

JO - Molecular Pharmaceutics

JF - Molecular Pharmaceutics

SN - 1543-8384

IS - 2

ER -